Hamilton Named Division Director
Dr. James (Jamie) Hamilton was named Director of the Division of Gastroenterology & Hepatology effective March 1. Dr. Hamilton has successfully served as interim director… Read More »Hamilton Named Division Director
Hendrix Receives Oscar B. Hunter Career Award in Therapeutics
Dr. Craig Hendrix, Professor Emeritus and former director of the Division of Clinical Pharmacology, recently received the Oscar B. Hunter Career Award in Therapeutics, the… Read More »Hendrix Receives Oscar B. Hunter Career Award in Therapeutics
Sex Hormones and Cardiovascular Risk in Type 2 Diabetes: Cohort Study of the Look AHEAD Trial
ARTICLE: Sex Hormones and Cardiovascular Risk in Type 2 Diabetes: Cohort Study of the Look AHEAD Trial AUTHORS: Teresa Gisinger, Jiahuan Helen He, Chigolum P Oyeka, Jianqiao Ma, Nityasree… Read More »Sex Hormones and Cardiovascular Risk in Type 2 Diabetes: Cohort Study of the Look AHEAD Trial
Match Day 2026
We are very proud to present to you the 2026 Intern Class for the Johns Hopkins Bayview Internal Medicine Residency Program, the Medicine-Pediatrics Urban Health… Read More »Match Day 2026
DOM WELL Committee
Introducing WELL: WELL is the DOM’s new advisory council dedicated to strengthening staff, trainee, and faculty well-being and fostering connection and belonging. If you are… Read More »DOM WELL Committee
Dynamics of natural and pharmacologic control of an SIV variant with an envelope trafficking defect
ARTICLE: Dynamics of natural and pharmacologic control of an SIV variant with an envelope trafficking defect AUTHORS: Kyle Rhodehouse, Carolin Zitzmann, Meghana Ravi, Ciara Armstrong, Milica Moskovljevic, Hannah P Moore, Courtney… Read More »Dynamics of natural and pharmacologic control of an SIV variant with an envelope trafficking defect
Acceptability and safety of one versus three months of rifapentine and isoniazid to prevent tuberculosis in people exposed in the household or workplace in Brazil: The Ultra-Curto randomized controlled trial
ARTICLE: Acceptability and safety of one versus three months of rifapentine and isoniazid to prevent tuberculosis in people exposed in the household or workplace in… Read More »Acceptability and safety of one versus three months of rifapentine and isoniazid to prevent tuberculosis in people exposed in the household or workplace in Brazil: The Ultra-Curto randomized controlled trial
Center for Innovative Medicine Next Generation Scholar Awards
We are very pleased to announce the call for the Center for Innovative Medicine Next Generation Scholar Awards. Through the generosity of the Johns Hopkins… Read More »Center for Innovative Medicine Next Generation Scholar Awards
Faculty Promotions & Additions
Congratulations to the faculty members below who were recently promoted. Associate Professor (pictured) Zoobia Chaudhry, General Internal Medicine Veronica Dioverti Prono, Infectious Diseases Ashwini Niranjan-Azadi, Hospital… Read More »Faculty Promotions & Additions
Susan M. MacDonald, MD Sponsorship Award
This award, sponsored by the Department of Medicine Task Force on Women’s Academic Careers in Medicine, recognizes a DOM faculty member who has demonstrated a… Read More »Susan M. MacDonald, MD Sponsorship Award